Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Globalization of ADHD and the rise of cognitive enhancement have raised fresh concerns about the validity of ADHD diagnosis and the ethics of stimulant drug treatment. We review the literature on these two emerging phenomena, with a focus on the corresponding social, scientific and ethical debates over the universality of ADHD and the use of stimulant drug treatments in a global population of children and adolescents. Drawing on this literature, we reflect on the importance of ethically informed, ecologically sensitive clinical practices in relation to ADHD diagnosis and treatment.

Original publication

DOI

10.1007/s11920-013-0385-0

Type

Journal article

Journal

Curr Psychiatry Rep

Publication Date

09/2013

Volume

15

Keywords

Attention Deficit Disorder with Hyperactivity, Bioethical Issues, Central Nervous System Stimulants, Ethics, Medical, Health Services Accessibility, Healthcare Disparities, Humans, Internationality